Kraig Biocraft Laboratories Issues a Letter to Shareholders on Recent Advancements and Potential Recombinant Spider Silk Deliveries in 2025

Stock Information for 23andMe Holding Co.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About 23andMe Holding Co.

24/7 Market News - Upgrades Signal Bright Future for Kraig Biocraft Labs and Spider Silk
Kraig Biocraft Laboratories Announces Senior Management Trip to Southeast Asia to Oversee Expansion of Spider Silk Production
24/7 Market News - Kraig Biocraft Advances Toward First-Ever Spider Silk Deliveries to Luxury and Performance Giants
Kraig Biocraft Laboratories Announces New Spider Silk Parental Strain for Expanded Commercial Production
Kraig Biocraft Laboratories Receives Business License to Begin Operations in Cambodia
Kraig Biocraft Laboratories Successfully Completes March/April Production Cycle; May Production Now Underway
Kraig Biocraft Laboratories Provides Production Update on Recombinant Spider Silk Operations
Kraig Biocraft Laboratories Announces the Launch of Advanced Gene-Splicing Program and New Transgenics

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.